218 related articles for article (PubMed ID: 24083678)
1. Sulindac activates NF-κB signaling in colon cancer cells.
Mladenova D; Pangon L; Currey N; Ng I; Musgrove EA; Grey ST; Kohonen-Corish MR
Cell Commun Signal; 2013 Oct; 11():73. PubMed ID: 24083678
[TBL] [Abstract][Full Text] [Related]
2. Sulindac sulfide-induced apoptosis involves death receptor 5 and the caspase 8-dependent pathway in human colon and prostate cancer cells.
Huang Y; He Q; Hillman MJ; Rong R; Sheikh MS
Cancer Res; 2001 Sep; 61(18):6918-24. PubMed ID: 11559570
[TBL] [Abstract][Full Text] [Related]
3. Growth-suppressive effect of non-steroidal anti-inflammatory drugs on 11 colon-cancer cell lines and fluorescence differential display of genes whose expression is influenced by sulindac.
Akashi H; Han HJ; Iizaka M; Nakamura Y
Int J Cancer; 2000 Dec; 88(6):873-80. PubMed ID: 11093808
[TBL] [Abstract][Full Text] [Related]
4. Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapy.
Zerbini LF; Tamura RE; Correa RG; Czibere A; Cordeiro J; Bhasin M; Simabuco FM; Wang Y; Gu X; Li L; Sarkar D; Zhou JR; Fisher PB; Libermann TA
PLoS One; 2011; 6(9):e24285. PubMed ID: 21931671
[TBL] [Abstract][Full Text] [Related]
5. The proapoptotic effects of sulindac, sulindac sulfone and indomethacin are mediated by nucleolar translocation of the RelA(p65) subunit of NF-kappaB.
Loveridge CJ; MacDonald AD; Thoms HC; Dunlop MG; Stark LA
Oncogene; 2008 Apr; 27(18):2648-55. PubMed ID: 18059344
[TBL] [Abstract][Full Text] [Related]
6. Sulindac inhibits activation of the NF-kappaB pathway.
Yamamoto Y; Yin MJ; Lin KM; Gaynor RB
J Biol Chem; 1999 Sep; 274(38):27307-14. PubMed ID: 10480951
[TBL] [Abstract][Full Text] [Related]
7. Annexin 1 induced by anti-inflammatory drugs binds to NF-kappaB and inhibits its activation: anticancer effects in vitro and in vivo.
Zhang Z; Huang L; Zhao W; Rigas B
Cancer Res; 2010 Mar; 70(6):2379-88. PubMed ID: 20215502
[TBL] [Abstract][Full Text] [Related]
8. Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines.
Han EK; Arber N; Yamamoto H; Lim JT; Delohery T; Pamukcu R; Piazza GA; Xing WQ; Weinstein IB
Breast Cancer Res Treat; 1998 Apr; 48(3):195-203. PubMed ID: 9598866
[TBL] [Abstract][Full Text] [Related]
9. Myeloid zinc finger 1 mediates sulindac sulfide-induced upregulation of death receptor 5 of human colon cancer cells.
Horinaka M; Yoshida T; Tomosugi M; Yasuda S; Sowa Y; Sakai T
Sci Rep; 2014 Aug; 4():6000. PubMed ID: 25102912
[TBL] [Abstract][Full Text] [Related]
10. Sulindac suppresses nuclear factor-kappaB activation and RANTES gene and protein expression in endometrial stromal cells from women with endometriosis.
Wieser F; Vigne JL; Ryan I; Hornung D; Djalali S; Taylor RN
J Clin Endocrinol Metab; 2005 Dec; 90(12):6441-7. PubMed ID: 16159934
[TBL] [Abstract][Full Text] [Related]
11. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis.
Piazza GA; Rahm AL; Krutzsch M; Sperl G; Paranka NS; Gross PH; Brendel K; Burt RW; Alberts DS; Pamukcu R
Cancer Res; 1995 Jul; 55(14):3110-6. PubMed ID: 7606732
[TBL] [Abstract][Full Text] [Related]
12. Sulindac enhances tumor necrosis factor-alpha-mediated apoptosis of lung cancer cell lines by inhibition of nuclear factor-kappaB.
Berman KS; Verma UN; Harburg G; Minna JD; Cobb MH; Gaynor RB
Clin Cancer Res; 2002 Feb; 8(2):354-60. PubMed ID: 11839649
[TBL] [Abstract][Full Text] [Related]
13. NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells.
Kim KH; Park SH; Do KH; Kim J; Choi KU; Moon Y
Oncotarget; 2016 Nov; 7(44):72148-72166. PubMed ID: 27708225
[TBL] [Abstract][Full Text] [Related]
14. HIF1α deficiency reduces inflammation in a mouse model of proximal colon cancer.
Mladenova DN; Dahlstrom JE; Tran PN; Benthani F; Bean EG; Ng I; Pangon L; Currey N; Kohonen-Corish MR
Dis Model Mech; 2015 Sep; 8(9):1093-103. PubMed ID: 26183215
[TBL] [Abstract][Full Text] [Related]
15. Sulindac metabolites induce caspase- and proteasome-dependent degradation of beta-catenin protein in human colon cancer cells.
Rice PL; Kelloff J; Sullivan H; Driggers LJ; Beard KS; Kuwada S; Piazza G; Ahnen DJ
Mol Cancer Ther; 2003 Sep; 2(9):885-92. PubMed ID: 14555707
[TBL] [Abstract][Full Text] [Related]
16. Docosahexaenoic acid sensitizes colon cancer cells to sulindac sulfide-induced apoptosis.
Lim SJ; Lee E; Lee EH; Kim SY; Cha JH; Choi H; Park W; Choi HK; Ko SH; Kim SH
Oncol Rep; 2012 Jun; 27(6):2023-30. PubMed ID: 22395735
[TBL] [Abstract][Full Text] [Related]
17. Sulindac enhances arsenic trioxide-mediated apoptosis by inhibition of NF-kappaB in HCT116 colon cancer cells.
Lee HR; Cheong HJ; Kim SJ; Lee NS; Park HS; Won JH
Oncol Rep; 2008 Jul; 20(1):41-7. PubMed ID: 18575716
[TBL] [Abstract][Full Text] [Related]
18. Sulindac inhibits tumor cell invasion by suppressing NF-κB-mediated transcription of microRNAs.
Li X; Gao L; Cui Q; Gary BD; Dyess DL; Taylor W; Shevde LA; Samant RS; Dean-Colomb W; Piazza GA; Xi Y
Oncogene; 2012 Nov; 31(48):4979-86. PubMed ID: 22286762
[TBL] [Abstract][Full Text] [Related]
19. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.
He Q; Luo X; Huang Y; Sheikh MS
Oncogene; 2002 Sep; 21(39):6032-40. PubMed ID: 12203115
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor preferentially activates the anti-inflammatory arm of NF-κB signaling to induce A20 and protect renal proximal tubular epithelial cells from inflammation.
da Silva CG; Maccariello ER; Wilson SW; Putheti P; Daniel S; Damrauer SM; Peterson CR; Siracuse JJ; Kaczmarek E; Ferran C
J Cell Physiol; 2012 Apr; 227(4):1382-90. PubMed ID: 21618526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
